<p>The present disclosure relates to antibodies directed to vascular endothelial growth factor (“VEGF”) and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of VEGF.</p>
申请公布号
EP2443150(A2)
申请公布日期
2012.04.25
申请号
EP20100725590
申请日期
2010.06.17
申请人
ABBOTT BIOTHERAPEUTICS CORP.
发明人
HARDING, FIONA;AKAMATSU, YOSHIKO;DUBRIDGE, ROBERT, B.;POWERS, DAVID, B.
